Can a change in screening and prescribing practice reduce the risk of venous thromboembolism in women taking the combined oral contraceptive pill?
The risk of Venous thromboembolism (VTE) associated with low dose combined oral contraceptive pills (COCs) is low at between 15 and 30 cases per 100 000 women years of use. Screening the total population or even those women with a family history of VTE in a first degree relative is unlikely to have a major impact on the number of cases of VTE associated with COC. Women with a known family history of an inherited thrombophilia should have this defect excluded before taking COCs. Women with a known thrombophilia or a personal history of VTE should consider alternative methods of contraception to the COC.
Mills
A
A
University College Hospitals London, The United Elizabeth Garrett Anderson Hospital & Hospital for Women Soho, London, UK.
Wilkinson
C
C
Fotherby
K
K
D000328:Adult; D003277:Contraceptives, Oral, Combined / Q000009:adverse effects*; D011307:Drug Prescriptions / Q000706:statistics & numerical data*; D005260:Female; D006801:Humans; D008403:Mass Screening / Q000706:statistics & numerical data*; D015233:Models, Statistical; D010818:Practice Patterns, Physicians'; D012306:Risk; D020246:Venous Thrombosis / Q000139:chemically induced* / Q000517:prevention & control*
D003277:Contraceptives, Oral, Combined